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11:00 AM – 12:30 PM Satellite Lunch Symposium:
Room 211 + 212 Personalized Management of Osteoarthritis: 
 Promise or Reality?
	 Sponsored	by	Bioiberica
12:30 PM – 2:00 PM Concurrent Session 1
Room 111  Signaling Pathways in OA
 Session Chairs:
 Hiroshi Kawaguchi, MD, PhD
 Sarah Snelling, PhD
12:30 PM – 1:00 PM  I-1. Signaling Pathways in Chondrocyte Pathology p. S1
 Frank Beier, PhD
1:00 PM – 1:12 PM 1. DKK3 CAN PREVENT CARTILAGE DEGRADATION AND MODULATE TGFBETA AND WNT p. S10 
 SIGNALLING
 S. Snelling1,2, R. Davidson1, T. Swingler1, A. Price2, I. Clark1; 
 1Univ. of East Anglia, Norwich, UNITED KINGDOM, 2Univ. of Oxford, Oxford, UNITED KINGDOM.
1:12 PM – 1:24 PM  2. EPIGENETIC REGULATION OF P16INK4A-MMP-1 AXIS IN OA-ASSOCIATED SENESCENCE-LIKE  p. S10 
 PHENOTYPE AND HYPERTROPHY OF CHONDROCYTES
  D. Philipot1,2, D. Guerit1,2, E. Olivotto3, D. Platano3, P. Chuchana1,2, j. Piette4, C. Jorgensen1,5, 
R. Borzi3, D. Noel1,2, j-m. Brondello1,2; 
  1INSERM U844, Montpellier, FRANCE, 2Université de Montpellier-1, Montpellier, FRANCE, 
3Laboratorio di immunoreumatologia e rigenerazione tissutale, Istituto di ricerca Codivilla Putti, 
Bologna, ITALY, 4CRBM UMR5535, Montpellier, FRANCE, 5Unité clinique, thérapeutiques des 
maladies des os et articulations, CHU Lapeyronie, Montpellier, FRANCE.
1:24 PM – 1:36 PM   3. LONG-DISTANCE PHYSICAL CONNECTIONS BETWEEN CHONDROCYTES; CELL-TO-CELL  p. S11 
COMMUNICATION
 WITHIN HYALINE CARTILAGE
  M. Mayán1, R. Gago1, P. Carpintero1, P. Filgueira- Fernández1, N. Goyanes1, V. Valiunas2, P. Brink2, 
F. J. Blanco1; 1Osteoarticular and Aging Res. Lab. INIBIC-CHUAC, A Coruña, SPAIN, 2Dept. of 
Physiology and Biophysics, State University of New York, Stony Brook, NY.
1:36 PM – 1:48 PM  4. SYNERGISTIC INDUCTION OF ELF3. IN VITRO EFFECT OF LEPTIN AND IL-1 IN HUMAN  p. S11 
 CHONDROCYTES
  J. Conde1, M. Scotece1, M. Otero2, R. Gomez1, J. J. Gomez-Reino1, M. B. Goldring2, O. Gualillo1; 
1SERGAS, Santiago Univ. Clinical Hosp. NEIRID LAB, Santiago de Compostela, SPAIN, 2Hosp. for 
Special Surgery, New York, NY.
1:48 PM – 2:00 PM  5.  NOTCH/RBPJ/HES1 SIGNAL IN CHONDROCYTES MODULATES OSTEOARTHRITIS DEVELOPMENT p. S11
  S. Sugita1, Y. Hosaka1, T. Hikata2, H. Akiyama3, F. Long4, U-i. Chung1, T. Saito1, H. Kawaguchi1; 
1the Univ. of Tokyo, Tokyo, JAPAN, 2Keio Univ., Tokyo, JAPAN, 3Kyoto Univ., Kyoto, JAPAN, 
4Washington Univ. in St. Louis, St. Louis, MO.
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12:30 PM – 2:00 PM Concurrent Session 2
Room 112 Clinical Relevance of Imaging in OA
 Session Chairs: 
 David Hunter, MBBS, PhD, FRACP
 Damien Loeuille, MBBS, PhD, FRACP
12:30 PM – 1:00 PM I-2. Clinical Relevance of Imaging in Osteoarthritis - The Radiologist’s Perspective  p. S1 
 Michel	D.	Crema,	MD
1:00 PM – 1:12 PM  6. CARTILAGE LOSS, MEASURED WITH MRI, PREDICTS KNEE REPLACEMENT - DATA FROM THE  p. S12 
OSTEOARTHRITIS INITIATIVE
  F. Eckstein1,2, C. K. Kwoh3, R. Boudreau4, Z. Wang3, M. J. Hannon3, S. Cotofana1,2, M. Hudelmaier1,2, 
W. Wirth1,2, A. Guermazi5,6, M. Nevitt7, M. R. John8, D. J. Hunter9, for the OAI investigators; 
1Paracelsus Med. Univ., Salzburg, AUSTRIA, 2Chondrometrics GmbH, Ainring, GERMANY, 3Univ. of 
Pittsburgh and Pittsburgh VAHS, Pittsburgh, PA, 4Univ. of Pittsburgh, Pittsburgh, PA, 5Boston Univ., 
Boston, MA, 6Boston Imaging Core Lab (BICL), Boston, MA, 7OAI Coordinating Ctr., UCSF, 
San Francisco, CA, 8Novartis Pharma AG, Basel, SWITZERLAND, 9Univ. Sydney, Sydney, AUSTRALIA.
1:12 PM – 1:24 PM  7. TOTAL HIP REPLACEMENT BUT NOT CLINICAL OSTEOARTHRITIS CAN BE PREDICTED BY SHAPE  p. S12 
VARIATIONS OF THE HIP: A PROSPECTIVE COHORT STUDY (CHECK)
  R. Agricola1, S. Bierma-Zeinstra1, J. Verhaar1, H. Weinans1,2, J. Waarsing1; 
1Erasmus Med. Ctr., Rotterdam, NETHERLANDS, 2Delft Univ. of Technology, Delft, NETHERLANDS.
1:24 PM – 1:36 PM  8. ASSESSMENT OF PERFUSION IN OSTEOARTHRITIS INDUCED BONE MARROW LESIONS USING  p. S13 
DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING
  J. P. Dyke1, D. Wheaton2, L. Ling2, C. Talmo2, W. F. Harvey2, D. J. Hunter3,2; 
1Weill Cornell Med. Coll., New York, NY, 2New England Baptist Hosp., Boston, MA, 
3Royal North Shore Hosp. and Northern Clinical Sch., Sydney, AUSTRALIA.
1:36 PM – 1:48 PM  9. PREVALENCE OF MEDIOPATELLAR PLICA IN SUBJECTS WITH KNEE PAIN AND THE ASSOCIATION  p. S13 
WITH PATELLOFEMORAL CARTILAGE DAMAGE AND BONE MARROW LESIONS: THE JOG STUDY
  L. XU1, D. Hayashi1, A. Guermazi1, C. Kwoh2, M. J. Hannon2, M. Jarraya1, F. W. Roemer1; 
1Boston Univ., Boston, MA, 2Univ. of Pittsburgh, Pittsburgh, PA.
1:48 PM – 2:00 PM  10. RADIOGRAPHIC JOINT SPACE NARROWING, MALALIGNMENT AND CLINICAL SOFT TISSUE SWELLING  p. S14 
ARE ASSOCIATED WITH MRI-DEFINED BONE MARROW LESIONS IN HAND OSTEOARTHRITIS
  I. K. Haugen1, P. Bøyesen1, B. Slatkowsky-Christensen1, S. Sesseng1, D. van der Heijde1,2, T. Kvien1; 
1Diakonhjemmet Hosp., Oslo, NORWAY, 2Leiden Univ. Med. Ctr., Leiden, NETHERLANDS.
2:00 PM – 2:30 PM BREAK
2:30 PM – 4:00 PM Concurrent Session 3
Room 111  Clinical Biomechanics and Rehabilitation
 Session Chairs: 
 Kim Bennell, PhD, PT 
 David Felson, MD, MPH
2:30 PM – 3:00 PM I – 3. Implications of Clinical Biomechanics Research on Rehabilitation for OA p. S1 
	 Trevor	Birmingham,	BA,	BSc,	MSc,	PhD
3:00 PM – 3:12 PM   11. SEVERITY OF PATELLOFEMORAL JOINT DISEASE IS ASSOCIATED WITH INCREASED FUNCTIONAL  p. S15 
LIMITATIONS AND LOWER LIMB IMPAIRMENTS IN PATIENTS WITH COEXISTING TIBIOFEMORAL 
OSTEOARTHRITIS
 S. Farrokhi, S. R. Piva, A. B. Gil, G. K. Fitzgerald; 
 Univ. of Pittsburgh, Pittsburgh, PA.
3:12 PM – 3:24 PM   12. EVALUATION OF THE LONGITUDINAL RELATIONSHIP BETWEEN THIGH MUSCLE MASS AND  p. S15 
WORSENING KNEE JOINT SPACE NARROWING
  N. A. Segal1, K. Wang2, C. Findlay1, J. C. Torner1, M. Nevitt3, for the Multicenter Osteoarthritis Study 
Group; 1Univ. of Iowa, Iowa City, IA, 2Boston Univ., Boston, MA, 3Univ. of California, San Francisco, 
San Francisco, CA.
3:24 PM – 3:36 PM   13. EFFECTS OF MODIFIED SHOES ON PARAMETERS OF KNEE LOAD IN INDIVIDUALS WITH KNEE  p. S16 
OSTEOARTHRITIS AND INDIVIDUALS WITH NO KNEE PAIN WHO ARE OF HEALTHY BODY WEIGHT  
AND THOSE WHO ARE OVERWEIGHT
 K. L. Bennell, C. O. Kean, T. V. Wrigley, R. S. Hinman; 
 Univ. of Melbourne, Melbourne, AUSTRALIA.
3:36 PM – 3:48 PM   14. THE RELATIONSHIP BETWEEN QUADRICEPS ANGLE DURING WALKING AND PATELLOFEMORAL  p. S17 
OSTEOARTHRITIS IN OLDER ADULTS: THE MOST STUDY
  K. Gross1,2, J. Niu2, Y. Tseng1, Y. Zhang2, H. J. Hillstrom3, D. J. Mattson1, M. C. Nevitt4, N. A. Segal5, 
C. E. Lewis6, D. T. Felson2; 
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1MGH Inst. of Hlth.Professions, Boston, MA, 2Boston Univ., Boston, MA, 3Hosp. for Special Surgery, 
New York, NY, 4Univesity of California, San Francisco, San Francisco, CA, 5Univ. of Iowa, Iowa City, 
IA, 6Univ. of Alabama, Birmingham, AL.
3:48 PM – 4:00 PM  15.  ROTATIONAL KNEE LOAD PREDICTS CARTILAGE LOSS OVER 12 MONTHS IN KNEE OSTEOARTHRITIS p. S17
  M. Henriksen1, R. S. Hinman2, M. W. Creaby3,2, F. Cicuttini4, B. R. Metcalf2, K-A. Bowles2, 
K. L. Bennell2; 1The Parker Inst., Copenhagen, DENMARK, 2Univ. of Melbourne, Melbourne, 
AUSTRALIA, 3Australian Catholic Univ., Brisbane, AUSTRALIA, 4Monash Univ., Melbourne, 
AUSTRALIA.
2:30 PM – 4:00 PM Concurrent Session 4
Room 112  New Imaging in Joint Tissue  
 Session Chairs: 
 Ali Guermazi, MD, PhD 
 Ingrid Möller
2:30 PM – 3:00 PM I – 4. Innovation in Molecular Imaging with Mass Spectrometry: Running Towards High Resolution p. S1 
 Ron	Heeren,	PhD
3:00 PM – 3:12 PM   16. MALDI IMAGING MASS SPECTROMETRY REVEALS A DIFFERENT PROTEIN DISTRIBUTION IN  p. S18 
HUMAN CONTROL AND OA CARTILAGE
  B. Cillero-Pastor1, G. Eijkel1, A. Kiss1, F. Blanco2, R. Heeren1; 
1AMOLF-FOM Inst., Amsterdam, NETHERLANDS, 2INIBIC-CHUAC, A Coruña, SPAIN.
3:12 PM – 3:24 PM   17. NON-INVASIVE SODIUM MR IMAGING AND QUANTIFICATION OF IN-VIVO ARTICULAR  p. S18 
CARTILAGE AT 1.5 TESLA
  A. M. Hani, D. Kumar, A. Malik, N. Walter; 
Universiti Teknologi Petronas, Tronoh, MALAYSIA.
3:24 PM – 3:36 PM  18. CARTILAGE T1RHO QUANTIFICATION IN ACL-RECONSTRUCTED KNEES: A 2-YEAR FOLLOW-UP p. S19
  X. Li1, F. Su2, S. Wu1, F. Liang1, T. Link1, S. Majumdar1, C. Ma1; 
1Univ. of California, San Francisco, San Francisco, CA, 2Univ. of California, Berkeley, Berkeley, CA.
3:36 PM – 3:48 PM   19. HISTOPATHOLOGICAL CHANGES IN THE HUMAN POSTERIOR CRUCIATE LIGAMENT DURING  p. S19 
AGING AND OSTEOARTHRITIS
  Y. Levy1,2, A. Hasegawa2, S. Patil1, M. Lotz2, D. D’Lima1,2; 
1Shiley Ctr. for Orthopaedic Res. and Ed. at Scripps Clinic, La Jolla, CA, 2The Scripps Res. Inst., 
La Jolla, CA.
3:48 PM – 4:00 PM  20. A NEW METHOD TO MEASURE ANATOMIC KNEE ALIGNMENT: A TOOL FOR LARGE STUDIES OF OA? p. S20
  T. Iranpour-Boroujeni1, J. Li2, J. Lynch2, M. Nevitt2, J. Duryea1; 
1Brigham and Women’s Hosp., Boston, MA, 2Univ. of California San Francisco, San Francisco, CA.
4:00 PM – 4:30 PM BREAK
4:30 PM – 6:00 PM Plenary Session 1
Room 111 + 112 Clinical Outcomes in OA
 Session Chairs:
 Maxime Dougados, MD 
 Gillian Hawker, MD, MSc
4:30 PM – 5:00 PM I – 5. Is It Time to Revisit the Symptomatic Outcome Variables to Assess OA Treatments? p. S2
	 Maxime	Dougados,	MD
5:00 PM – 5:12 PM  21.  RETURN TO WORK AND WORK ACTIVITY LIMITATIONS FOLLOWING TOTAL HIP AND KNEE  p. S21 
REPLACEMENT
  A. Sankar1, M. A. Gignac2, M. P. Palaganas3, E. M. Badley2, D. E. Beaton4, A. M. Davis5; 
1Div. of Hlth.Care and Outcomes Res., Toronto Western Res. Inst., Univ. Hlth.Network and Faculty 
of Med., Univ. of Toronto, Toronto, ON, CANADA, 2Div. of Hlth.Care and Outcomes Res., Toronto 
Western Res. Inst., Univ. Hlth.Network and Dalla Lana Sch. of Publ. Hlth., Univ. of Toronto, Toronto, 
ON, CANADA, 3Div. of Hlth.Care and Outcomes Res., Toronto Western Res. Inst., Univ. Hlth.Network, 
Toronto, ON, CANADA, 4Keenan Res. Inst., St. Michael’s Hosp. and Dept.s of Occupational Therapy 
and Rehabilitation Sci., Univ. of Toronto, Toronto, ON, CANADA, 5Div. of Hlth.Care and Outcomes 
Res., Toronto Western Res. Inst.; Dept.s of Rehabilitation Sci. and Hlth.Policy, Management and 
Evaluation, Univ. of Toronto, Toronto, ON, CANADA.
5:12 PM – 5:24 PM   22. BODY FAT AND LEAN MASS HAVE OPPOSITE EFFECTS ON LOSS OF KNEE CARTILAGE AND  p. S21 
INCREASE IN KNEE PAIN IN OLDER ADULTS: A PROSPECTIVE COHORT STUDY
  C. Ding1, O. Stannus1, B. Antony1, F. Cicuttini2, G. Jones1; 
1Univ. of Tasmania, Hobart, AUSTRALIA, 2Monash Univ., Melbourne, AUSTRALIA.
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5:24 PM – 5:36 PM   23. WEIGHT LOSS IS NOT ASSOCIATED WITH A REDUCTION IN THE RATE OF DECLINE IN JOINT  p. S21 
SPACE WIDTH IN SUBJECTS WITH SYMPTOMATIC RADIOGRAPHIC KNEE OSTEOARTHRITIS: DATA  
FROM THE OSTEOARTHRITIS INITIATIVE
  M. C. Hochberg1, D. Bujak1, K. Favors1, J. D. Sorkin1, J. Duryea2; 
1Univ. of Maryland, Baltimore, MD, 2Brigham & Women’s Hosp., Boston, MA.
5:36 PM – 5:48 PM   24. PATTERN OF INVOLVEMENT AND RISK PROFILE OF SYMPTOMATIC EROSIVE OSTEOARTHRITIS:  p. S22 
RESULTS OF AN EXPLORATORY POPULATION-BASED STUDY
  M. Marshall1, E. Nicholls1, W-Y. Kwok2, M. Kloppenburg2, D. van der Windt1, H. Myers1, 
K. Dziedzic1, G. Peat1; 
1Arthritis Res. UK Primary Care Ctr., Keele Univ., Staffordshire, UNITED KINGDOM, 2Dept. of 
Rheumatology, Leiden Univ. Med. Ctr., Leiden, NETHERLANDS.
5:48 PM – 6:00 PM   25. MEDIAL JOINT-SPACE WIDTH IS ASSOCIATED WITH PREVALENT AND INCIDENT KNEE PAIN  p. S22 
AND SEVERITY: THE OSTEOARTHRITIS INITIATIVE
  Y. Zhang1, J. Niu1, J. Duryea2, T. Neogi1; 
1Boston Univ., Boston, MA, 2Brigham and Women’s Hosp., Boston, MA.
6:00 PM – 6:15 PM BREAK
6:15 PM – 8.00 PM
Room 111 + 112 Opening Ceremony
6:15 PM – 6:45 PM Presidential Address
	 Linda	Sandell,	PhD
6:45 PM – 6:50 PM Recognition of Young Investigators
6:50 PM – 7:00 PM Lifetime Achievement Recognition
 David Felson, MD, MPH
7:00 PM – 7:15 PM Basic Science Award Presentation
  Genomic Study of Osteoarthritis - Past, Present and Future
	 Shiro	Ikegawa,	MD,	PhD
7:15 PM – 7:30 PM Clinical Science Award Presentation
	 Michael	Doherty,	MD,	MA,	FRCP,	ILTM
 Risk Factors for OA and Associated Pain
7:30 PM – 8:00 PM I – 6. Keynote Lecture: Cartilage and Joint Development p. S2
	 Veronique	Lefebvre,	PhD
8:00 PM – 9:30 PM Opening Reception with Exhibitors
 Exhibit Hall
Friday, April 27, 2012
7.30 AM – 8:30 AM Breakfast Workshop A – 
 In Vitro Models to Study
Room 131 + 132 Cartilage Biology and Osteoarthritis
	 Martin	Lotz,	MD	
 **Ticketed Workshop.
7.30 AM – 8.30 AM  Breakfast Workshop B – 
 I – 7. Update on Pharmacologic Management of OA p. S2
Room 133 + 134  Thomas	Schnitzer,	MD,	PhD
 **Ticketed Workshop.
8:30 AM – 10:00 AM Plenary Session 2 
Room 111 + 112 Highest Rated Abstracts from Young Investigators
 Session Chairs: 
 Francis Berenbaum, MD, PhD
 Linda Sandell, PhD
8:30 AM – 8:40 AM  26.  THE ASSOCIATION BETWEEN HIP MORPHOLGY AND 19-YEAR RISK OF OSTEOARTHRITIS IN THE HIP p. S23
  G. E. Thomas1, R. N. Batra1, A. Kiran1, S. Pennant1, D. Hart2, T. Spector2, H. S. Gill1, M. K. Javaid1, 
A. J. Carr1, N. K. Arden1,3, S. Glyn-Jones1; 
1NIHR BioMed. Res. Unit, NDORMS, Univ. of Oxford, Oxford, UNITED KINGDOM, 2Dept. of Twin Res. 
& Genetic Epidemiology, Kings Coll., London, UNITED KINGDOM, 3MRC Lifecourse Epidemiology 
Unit, Univ. of Southampton, Southampton, UNITED KINGDOM.
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8:40 AM – 8:50 AM   27. CORRELATIONS BETWEEN REPORTED AND OBSERVED WALKING ABILITY IN PEOPLE WITH KNEE  p. S24 
AND HIP OSTEOARTHRITIS.
  l. R. brunton1, a. J. smith1, a. W. blom1, p. juni2, p. dieppe1; 
1Univ. of bristol, bristol, UNITED KINGDOM, 2Univ. of bern, bern, SWITZERLAND.
8:50 AM – 9:00 AM   28. THE ASSOCIATION BETWEEN RADIOGRAPHIC HAND OSTEOARTHRITIS AND MENISCAL  p. S24 
DAMAGE ON MRI IN THE GENERAL POPULATION
  M. Englund1,2, I. K. Haugen3, A. Guermazi2, F. W. Roemer4,2, J. Niu2, T. Neogi2, P. Aliabadi5, M. Clancy2, 
D. T. Felson2; 
1Lund Univ., Lund, SWEDEN, 2Boston Univ. Sch. of Med., Boston, MA, 3Diakonhjemmet Hosp., Oslo, 
NORWAY, 4Klinikum Augsburg, Augsburg, GERMANY, 5Brigham and Women’s Hosp., Boston, MA.
9:00 AM – 9:10 AM   29. SYNOVIAL WNT AND WISP1 EXPRESSION INDUCES CARTILAGE DAMAGE BY SKEWING  p. S25 
OF TGF-BETA SIGNALING AND REDUCTION OF THE ANTI-HYPERTROPHIC FACTOR SOX9
  M. H. van den Bosch, A. B. Blom, P. L. van Lent, H. M. van Beuningen, F. A. van de Loo, 
E. N. Blaney Davidson, P. M. van der Kraan, W. B. van den Berg;  
Radboud Univ. Nijmegen Med. Ctr., NCMLS, Nijmegen, NETHERLANDS.
9:10 AM – 9:20 AM   30. DISRUPTION OF SIRT1 IN CHONDROCYTES CAUSES ACCELERATED DEVELOPMENT OF  p. S25 
OSTEOARTHRITIS INDUCED BY JOINT INSTABILITY IN THE MOUSE
  T. Matsuzaki, T. Matsushita, S. Kubo, T. Matsumoto, H. Sasaki, K. Takayama, M. Kurosaka, R. Kuroda; 
Kobe Univ. Graduate Sch. of Med., Kobe, Hyogo, JAPAN.
9:20 AM – 9:30 AM   31. SYNDECAN-4 IS CRITICALLY INVOLVED IN INFLAMMATORY DRIVEN BONE FRACTURE REPAIR,  p. S25 
BUT NOT FETAL SKELETAL DEVELOPMENT
  J. Bertrand1, R. Stange2, H. Hidding2, F. Echtermeyer3, G. Nalesso1, L. Godmann4, F. Dell’Accio1, 
T. Pap4, R. Dreier5; 
1William Harvey Inst., London, UNITED KINGDOM, 2Dept. of Trauma, Hand and Reconstructive 
Surgery, Muenster, GERMANY, 3Dept. of Anaesthesiology and Intensive Care Med.,, Hanover, 
GERMANY, 4Inst. for Experimental Musculoskeletal Med., Muenster, GERMANY, 5Inst. for 
Physiological Chemistry and Pathobiochemistry, Muenster, GERMANY.
9:30 AM – 9:40 AM   32. ARTHROSCOPIC PARTIAL MEDIAL MENISCECTOMY IS ASSOCIATED WITH HIGHER MEDIAL KNEE  p. S26 
JOINT LOAD AND REDUCTIONS IN MEDIAL ARTICULAR CARTILAGE VOLUME DESPITE TYPICAL KNEE  
STRENGTH AT 2 YEARS POST-SURGERY
  K. L. Bennell1, T. V. Wrigley1, F. M. Cicuttini2, B. R. Metcalf1, M. Hall1, A. R. Dempsey3, 
P. M. Mills3, R. S. Hinman1, Y. Wang2, D. G. Lloyd3; 
1The Univ. of Melbourne, Melbourne, AUSTRALIA, 2Monash Univ., Melbourne, AUSTRALIA, 
3Griffith Univ., Queensland, AUSTRALIA.
9:40 AM – 9:50 AM   33. EFFECTIVE KNOCK DOWN OF MMP13 BY INTRA-ARTICULAR INJECTION OF SMALL  p. S26 
INTERFERING RNA (siRNA) IN MURINE SURGICALLY INDUCED OSTEOARTHRITIS MODEL
  R. Akagi1, T. Sasho1, M. Saito1, N. Ikegawa1, S. Mukoyama1, Y. Muramatsu1, S. Yamaguchi1, 
K. Nakagawa2, K. Takahashi1; 
1Chiba Univ. Hosp., Chiba, JAPAN, 2Sakura Med. Ctr. Toho Univ. Hosp., Chiba, JAPAN.
9:50 AM – 10:00 AM   34. FIVE TO TEN YEAR FOLLOW UP OF MATRIX ASSOCIATED AUTOLOGOUS CHONDROCYTE  p. S27 
TRANSPLANTATION (MACT) IN THE KNEE
  M. Brix1, C. Chiari1, S. Nehrer2, R. Windhager1, S. Domayer1; 
1Med. Univ. of Vienna, Vienna, AUSTRIA, 2Danube Univ. Krems, Krems, AUSTRIA.
10:00 AM – 10:30 AM OARSI Business Meeting
Room 111 + 112
10:30 AM – 11:00 AM BREAK
Exhibit Hall
11:00 AM – 12:30 PM Concurrent Session 5
Room 111 Targeted Therapy Trials
 Session Chairs: 
 Xavier Chevalier, MD
 Timothy McAlindon, MD, MPH
  
11:00 AM – 11:30 AM I -8. Novel and Targeted Therapies p. S3 
		 Nancy	Lane,	MD
11:30 AM – 11:42 AM 35.  A PHASE IIA CLINICAL STUDY OF TISSUEGENE-C (TG-C) IN PATIENTS WITH OSTEOARTHRITIS p. S27
  C-W. Ha1, S. H. Park2, J. J. Cho2, T. W. Kim2, M. J. Noh3, M. C. Lee4; 
1Samsung Med. Ctr., Seoul, KOREA, REPUBLIC OF, 2Kolon Life Sci., GwaChun, KOREA, REPUBLIC OF, 
3TissueGene, Inc, Rockville, MD, 4Seoul Natl. Univ. Hosp., Seoul, KOREA, REPUBLIC OF.
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11:42 AM – 11:54 AM  36. THE INTENSIVE DIET AND EXERCISE FOR ARTHRITIS TRIAL (IDEA): EFFECTS ON KNEE JOINT  p. S28 
LOADING AND INFLAMMATION
  S. P. Messier1, P. DeVita2, B. J. Nicklas3, D. Beavers3, S. Mihalko1, G. D. Miller1, M. Lyles3, D. J. Hunter4, 
F. Eckstein5, C. Legault3, J. D. Williamson3, J. J. Carr3, R. F. Loeser3; 
1Wake Forest Univ., Winston-Salem, NC, 2East Carolina Univ., Greenville, NC, 3Wake Forest Univ. 
Sch. of Med., Winston-Salem, NC, 4Univ. of Sydney, Sydney, AUSTRALIA, 5Paracelsus Med. Univ., 
Salzburg, AUSTRIA.
11:54 AM – 12:06 PM  37. EFFICACY AND SAFETY OF LONG-TERM REPEATED, INTRA-ARTICULAR INJECTIONS OF  p. S28 
HYALURONIC ACID IN KNEE OSTEOARTHRITIS: FINAL RESULTS OF THE AMELIA TRIAL
  F. Navarro-Sarabia1, P. Coronel2, F. Blanco3, A. Rodriguez de la Serna4, M. Gimeno2, 
G. Herrero-Beaumont5, on behalf of AMELIA study group; 
1Hosp. Virgen Macarena, Sevilla, SPAIN, 2Tedec Meiji Farma SA, Alcalá de Henares, SPAIN, 
3Hosp. Juan Canalejo, La Coruña, SPAIN, 4Hosp. Santa Creu i Sant Pau, Barcelona, SPAIN, 
5Fundación Jiménez Díaz, Madrid, SPAIN.
12:06 PM – 12:18 PM  38. PREVENTION OF KNEE OSTEOARTHRITIS IN OVERWEIGHT FEMALES; THE FIRST PREVENTIVE  p. S29 
RANDOMIZED CONTROLLED TRIAL
  J. Runhaar1, M. van Middelkoop1, D. Vroegindeweij2, E. H. Oei1, M. Reijman1, G. J. van Osch1, 
B. W. Koes1, S. M. Bierma-Zeinstra1; 
1Erasmus MC, Rotterdam, NETHERLANDS, 2Maasstad Hosp., Rotterdam, NETHERLANDS.
12:18 PM – 12:30 PM  39. CARTILAGE LOSS DURING SYMPTOMATIC MAINTENANCE AFTER A CLINICALLY SIGNIFICANT  p. S29 
WEIGHT LOSS IN OBESE OSTEOARTHRITIS PATIENTS: A RANDOMIZED CONTROLLED TRIAL
  M. Henriksen1, R. Christensen1,2, D. J. Hunter3, E. Dam4, S. Lohmander2,5, M. Boesen1,6, 
H. Gudbergsen1, H. Bliddal1; 
1The Parker Inst., Copenhagen, DENMARK, 2Univ. of Southern Denmark, Odense, DENMARK, 
3Univ. of Sydney, Sydney, AUSTRALIA, 4Biomediq, Copenhagen, DENMARK, 5Univ. of Lund, Lund, 
SWEDEN, 6Dept. of Radiology, Frederiksberg Hosp., Copenhagen, DENMARK.
11:00 AM – 12:30 PM Concurrent Session 6
Room 112 Cartilage ECM
 Session Chairs: 
 Amanda Fosang, PhD
 Mary Goldring, PhD
11:00 AM – 11:30 AM I - 9. Perifibrillar Proteins in the Cartilage Extracellular Matrix p. S3 
		 Raimund	Wagener,	PhD
11:30 AM – 11:42 AM  40. BLOCKING COLLAGENOLYSIS PREVENTS AGGRECAN LOSS MORE EFFECTIVELY THAN BLOCKING  p. S30 
AGGRECANOLYSIS IN THE AGGRECAN INTERGLOBULAR DOMAIN, IN VITRO AND IN VIVO
  S. J. Gauci1, C. B. Little2, A. J. Fosang3; 
1Murdoch Childrens Res. Inst., VIC, AUSTRALIA, 2Raymond Purves Bone & Joint Res. Labs, Univ. of 
Sydney, NSW, AUSTRALIA, 3Univ. of Melbourne & Murdoch Childrens Res. Inst., VIC, AUSTRALIA.
11:42 AM – 11:54 AM  41. S100A8 AND S100A9 ACT AS ‘PRIMERS’ OF A CATABOLIC RESPONSE IN CHONDROCYTES BUT  p. S30 
ADDITIONAL SIGNALS ARE REQUIRED TO ACTIVATE CARTILAGE DEGRADATION
  A. van Hummel1,2, C. Little2, T. Vogl3, J. Roth3, H. Zreiqat1; 
1Tissue Engineering and Biomaterials Unit, Faculty of Engineering, The Univ. of Sydney, Sydney, 
AUSTRALIA, 2Raymond Purves Bone & Joint Res. Lab., The Kolling Inst. Of Med. Res., Univ. of 
Sydney, Royal North Shore Hosp., Sydney, AUSTRALIA, 3Inst. of Immunology, Univ. of Muenster, 
Muenster, GERMANY.
11:54 AM – 12:06 PM  42. CONNECTIVE TISSUE GROWTH FACTOR/CCN FAMILY 2 IS A PERICELLULAR PROTEIN WHOSE  p. S31 
CELLULAR RESPONSE IS DEPENDENT UPON THE TGF TYPE I RECEPTOR
  X. Tang, C. McLean, T. Vincent; 
Imperial Coll. London, London, UNITED KINGDOM.
12:06 PM – 12:18 PM  43. DEVELOPMENT OF PAIN AND FUNCTION IN 3 YEARS OF FOLLOW-UP; COMPARISON BETWEEN  p. S31 
CHECK study (COHORT HIP & COHORT KNEE) AND OSTEOARTHRITIS INITIATIVE
  J. Wesseling1, S. M. Bierma- Zeinstra2, G. Kloppenburg3, J. W. Bijlsma1, on behalf of the CHECK 
steering group;  
1Univ. Med. Ctr. Utrecht, Utrecht, NETHERLANDS, 2Erasmus Med. Ctr., Rotterdam, NETHERLANDS, 
3Leiden Univ. Med. Ctr., Leiden, NETHERLANDS.
12:18 PM – 12:30 PM  44. NLRP3 INFLAMMASOME PLAYS A CRITICAL ROLE IN THE PATHOGENESIS OF  p. S32 
HYDROXYAPATITE-ASSOCIATED ARTHROPATHY
  C. Jin1, P. Frayssinet2, R. Flavell1; 
1Yale Univ., New Haven, CT, 2Le Gaillard, St Lys, FRANCE.
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12:30 PM – 2:00 PM Satellite Lunch Symposium
Room 211 + 212 Impact of Synovitis on Disease Progression in  
 Osteoarthritis
	 Sponsored	by	Bioiberica
2:00 PM – 3:30 PM Plenary Session 3
Room 111 + 112 OA Biomarkers
 Session Chairs: 
 Yves Henrotin, PhD
 Ali Mobasheri, BSc ARCS, MSc, DPhil
2:00 PM – 2:30 PM I - 10. OA Biomarkers: How Do We Recognize The Real McCoy? p. S3 
		 George	Moxley,	MD	
2:30 PM – 2:42 PM   45. ELECTROARTHROGRAPHY: ELECTRICAL POTENTIALS MEASURED AT THE SURFACE OF THE KNEE  p. S32 
DURING MECHANICAL LOADING OF THE JOINT ORIGINATE FROM THE ARTICULAR CARTILAGE AND  
CAN ASSESS CARTILAGE DEGRADATION IN PATIENTS WITH OSTEOARTHRITIS
  A-M. Préville1, P. Lavigne2, M. Buschmann1, J. Hardin3, Q. Han1, L. Djerroud1, P. Savard1; 
1Ecole Polytechnique de Montréal, Montreal, QC, CANADA, 2Hôpital Maisonneuve-Rosemont, 
Montreal, QC, CANADA, 3Albert Einstein Coll. of Med., New York, NY.
2:42 PM – 2:54 PM   46. EXPLORATORY ANALYSIS OF A WIDE SPECTRUM OF BIOCHEMICAL MARKERS IN A LARGE  p. S32 
COHORT OF INDIVIDUALS WITH SYMPTOMS OF VERY EARLY KNEE AND HIP OSTEOARTHRITIS:  
DATA FROM CHECK
  W. E. van Spil, N. W. Jansen, S. C. Mastbergen, J. W. Bijlsma, P. M. Welsing, F. P. Lafeber; 
Univ. Med. Ctr. Utrecht, Utrecht, NETHERLANDS.
2:54 PM – 3:06 PM   47. LARGE BONE MARROW LESIONS AND WORSENING OF BONE MARROW LESIONS IN THE MEDIAL  p. S32 
TIBIO-FEMORAL COMPARTMENT ARE ASSOCIATED WITH KNEES UNDERGOING TOTAL KNEE  
REPLACEMENT : DATA FROM THE OSTEOARTHRITIS INITIATIVE
  F. W. Roemer1,2, C. K. Kwoh3, D. J. Hunter4, B. Boudreau3, M. J. Hannon3, L. Xu1, F. Eckstein5,6, 
Z. Wang3, M. R. John7, A. Guermazi1, for the OAI Investigators; 
1Boston Univ. Sch. of Med., Boston, MA, 2Klinikum Augsburg, Augsburg, GERMANY, 3Univ. of 
Pittsburgh, Pittsburgh, PA, 4Univ. of Sydney, Sydney, AUSTRALIA, 5Paracelsus Univ. Salzburg, 
Salzburg, AUSTRIA, 6Chondrometrics GmbH, Ainring, GERMANY, 7Novartis, Basel, SWITZERLAND.
3:06 PM – 3:18 PM   48. STRUCTURAL BIOMARKERS PREDICT ONSET OF KNEE PAIN: DATA FROM THE OSTEOARTHRITIS  p. S33 
INITIATIVE
  J. G. Tamez-Pena1,2, P. C. Gonzalez2, E. H. Schreyer2, S. M. Totterman2; 
1Tecnologico de Monterrey, Escuala de Med., Monterrey, MEXICO, 2Qmetrics Technologies, 
Rochester, NY.
3:18 PM – 3:30 PM   49. INFLAMMATORY GENOMIC AND PLASMA BIOMARKERS PREDICT PROGRESSION OF  p. S33 
SYMPTOMATIC KNEE OA (SKOA)
  M. Attur1, A. Statnikov2, C. F. Aliferis2, Z. Li2, S. Krasnokutsky1, J. Samuels1, J. D. Greenberg1, J. Patel1, 
C. Oh1, Q. A. Lu3, R. Ramirez3, J. Todd3, S. B. Abramson1; 
1NYU Hosp. for Joint Diseases, New York, NY, 2Ctr. for Hlth.Informatics and Bioinformatics, 
New York, NY, 3Singulex, Alameda, CA.
3:30 PM – 5:00 PM Poster Session 1: Presenters in Attendance 
 Exhibit Hall
 Even Posters 3:30 PM – 4:15 PM
 Odd Posters 4:15 PM – 5:00 PM
5:00 PM – 6:06 PM Concurrent Session 7
Room 111 New Target Proteins in OA  
 Session Chairs: 
 Cristina Ruiz-Romero, PhD
 Wim van den Berg, PhD
5:00 PM – 5:30 PM I - 11. The Global Human Proteome Project and its Relevance for  Osteoarthritis  p. S4 
		 Gilbert	Omenn,	MD,	PhD
5:30 PM – 5:42 PM   50. SYNERGISTIC CHONDROPROTECTIVE EFFECT OF CHONDROTIN SULFATE AND GLUCOSAMINE:  p. S35 
A PHARMACOPROTEOMIC STUDY.
  V. Calamia1, J. Mateos1, P. Fernández-Puente1, L. Lourido1, E. Montell2, J. Vergés2, 
C. Ruiz-Romero1, F. J. Blanco1;  
1INIBIC-CHUAC. ProteoRed/ISCIII. Proteomic Group. Rheumatology Div., A Coruña, SPAIN, 
2Pharmacological Res. Unit, Scientific Med. Dept., Bioibérica, S.A., Barcelona, SPAIN.
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5:42 PM – 5:54 PM   51. QUANTITATIVE PROTEOMICS OF DIFFERENT ZONES IN HUMAN ARTICULAR CARTILAGE REVEALS  p. S36 
UNIQUEPATTERNS OF PROTEIN DISTRIBUTION
  C. Müller1, A. Khabut2, A. Aspberg1, D. Heinegård2, J. Dudhia3, P. Önnerfjord2; 
1Dept. of Biology, Copenhagen, DENMARK, 2Clinical Sci., Lund, SWEDEN, 3Vet. Clinical Sci., London, 
UNITED KINGDOM.
5:54 PM – 6:06 PM   52. VERIFICATION OF POTENTIAL DISEASE BIOMARKERS IN MESENCHYMAL STEM CELLS FROM  p. S36 
OSTEOARTHRITIS PATIENTS BY SELECTED REACTION MONITORING ASSAYS
  J. Lamas1, E. Camafeita2, E. Calvo2, P. Tornero-Esteban1, J. Lopez2, B. Fernandez-Gutierrez1; 
1Hosp. Clinico San Carlos, Madrid, SPAIN, 2CNIC, Madrid, SPAIN.
5:00 PM- 6:06 PM Concurrent Session 8 
Room 112 Expectation and Outcome for Surgical Treatment
 Session Chairs: 
 Qing Jiang, MD, PhD 
 Serge Poiraudeau, MD, PhD
5:00 PM – 5:30 PM  I - 12. Surgical Management of Osteoarthritis: Options and Outcomes p. S4
	 Jeffrey	Katz,	MD,	MSc
5:30 PM – 5:42 PM   53. A RANDOMISED CONTROLLED TRIAL OF CEMENTED VERSUS CEMENTLESS FIXATION IN OXFORD  p. S36 
UNICOMPARTMENTAL KNEE REPLACEMENT IN THE TREATMENT OF MEDIAL GONARTHROSIS USING 
RADIOSTEREOMETRIC ANALYSIS
  B. J. Kendrick, N. J. Bottomley, H. S. Gill, W. F. Jackson, C. A. Dodd, A. J. Price, D. W. Murray; 
Univ. of Oxford, Oxford, UNITED KINGDOM.
5:42 PM – 5:54 PM   54. CLINICAL OUTCOME AFTER TOTAL KNEE REPLACEMENT: FORGOTTEN KNEE. A SINGLE-CENTRE  p. S37 
PROSPECTIVE PRAGMATIC STUDY
  m. Bercovy, Sr.1, X. Chevalier, Sr.2; 
1Hosp. Henri Mondor, Centre Medical Vauban, Paris, FRANCE, 2Hosp. Henri Mondor, Creteil, FRANCE.
5:54 PM – 6:06 PM   55. ASSOCIATIONS BETWEEN PRE-OPERATIVE RADIOGRAPHIC CHANGES AND OUTCOMES AFTER  p. S37 
TOTAL KNEE JOINT REPLACEMENT FOR OSTEOARTHRITIS
  M. Dowsey1, M. Nikpour1, P. Choong1, P. Dieppe2; 
1St Vincent’s Hosp., Melbourne, AUSTRALIA, 2Peninsula Med. Sch., Plymouth, UNITED KINGDOM.
6:15 PM – 6:45 PM Late Breaking Abstracts
Room 112
 Session Chairs: 
	 Francisco	Blanco,	MD,	PhD	
	 Francois	Rannou,	MD,	PhD
6:15 PM – 6:25 PM   56. A 2-YEAR RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF AN  p. S38 
ORAL SELECTIVE INOS INHIBITOR IN SUBJECTS WITH SYMPTOMATIC OSTEOARTHRITIS OF THE KNEE
  M-P. Hellio le Graverand-Gastineau1, R. Clemmer1, P. Redifer1, R. M. Brunell1, C. W. Hayes2, 
K. Brandt3, S. B. Abramson4, P. T. Manning5, C. G. Miller6, E. Vignon7; 
1Pfizer Inc, Primary Care Med.s Dev. Group, Groton, CT, 2Virginia Commonwealth Univ. Hlth.System, 
Richmond, VA, 3Kansas Univ. Med. Ctr., Kansas City, KS, 4New York Sch. of Med., New York, NY, 
5Vasculox, Inc, St Louis, MO, 6BioClinica Inc, Newtown, PA, 7Claude Bernard Univ., Lyon, FRANCE.
6:25 PM – 6:35 PM   57. INFLAMMATORY BIOMARKERS OF OA, IL-6 AND LEPTIN ARE MODIFIABLE IN OVERWEIGHT/OBESE  p. S38 
OA PATIENTS WITH A PROTOCOL THAT COMBINES TRAINING IN PAIN COPING SKILLS AND WEIGHT 
MANAGEMENT
  J. L. Huebner, L. R. Landerman, T. J. Somers, V. B. Kraus, F. Guilak, J. A. Blumenthal, D. S. Caldwell, 
J. R. Rice, F. J. Keefe; Duke Univ. Med. Ctr., Durham, NC.
6:35 PM – 6:45 PM   58. ABNORMAL PROCESSING OF TYPE II COLLAGEN IN CARTILAGE-SPECIFIC SITE-1 PROTEASE  p. S38 
KNOCKOUT MICE
  D. Patra, E. DeLassus, J. Mueller, L. J. Sandell; 
Washington Univ. Sch. of Med., St. Louis, MO.
6:45 PM – 8:15 PM Young Investigator’s Mentorship Session 
Room 211 + 212
8:15 PM – 9:30 PM Young Investigator’s Reception
2012 OARSI World Congress Program  xv
Saturday, April 28, 2012
7.30 AM – 8:30 AM Breakfast Workshop C – 
 I - 13. Technical Developments in Genetic Modified Animal Model p. S4
Room 131 + 132 Peter	van	der	Kraan,	PhD
 **Ticketed Workshop.
7.30 AM – 8:30 AM Breakfast Workshop D – Methodological Issues in
Room 133 + 134 Clinical Biomechanics and Gait Analysis
	 Lynn	Snyder-Macklar,	PT,	ScD,	FAPTA
 **Ticketed Workshop.
8:45 AM – 10:15 AM Concurrent Session 9
Room 111 Biological Surgical Repair 
  Session Chairs: 
Stefan Lohmander, MD 
Leonardo Punzi, MD, PhD
8:45 AM – 9:15 AM I - 14. Biological Joint Reconstruction p. S4 
		 Andreas	Gomoll,	MD
9:15 AM – 9:27 AM  59. INORGANIC POLYPHOSPHATE EXHIBITS ANABOLIC EFFECTS ON ARTICULAR CARTILAGE p. S39
  J-P. St-Pierre, J. N. De Croos, J. S. Theodoropoulos, M. Petrera, P. Sharma, S. Li, R. M. Pilliar, 
M. D. Grynpas, R. A. Kandel;  
CIHR-BioEngineering of Skeletal Tissues Team, Mount Sinai Hosp. and Univ. of Toronto, Toronto, 
ON, CANADA.
9:27 AM – 9:39 AM   60. SECOND GENERATION CHARACTERIZED CHONDROCYTE IMPLANTATION FOR THE TREATMENT OF  p. S39 
CARTILAGE LESIONS IN THE KNEE
  A. A. Dhollander, P. C. Verdonk, S. Lambrecht, R. Verdonk, D. Elewaut, G. Verbruggen, F. Almqvist; 
Ghent Univ., Ghent, BELGIUM.
9:39 AM – 9:51 AM  61. LONG TERM FOLLOWUP OF FRESH OSTEOCHONDRAL ALLOGRAFTING OF THE FEMORAL CONDYLE p. S40
  Y. Levy1,2, S. Görtz3, P. Pulido1, J. McCauley1, W. Bugbee4; 
1Shiley Ctr. for Orthopaedic Res. & Ed. at Scripps Clinic, La Jolla, CA, 2Tel Aviv Med. Ctr., Div. of 
Orthopaedic Surgery, Tel Aviv, ISRAEL, 3Univ. of California, San Diego Med. Ctr., san diego, CA, 
4Scripps Clinic, Div. of Orthopaedic Surgery, La Jolla, CA.
9:51 AM – 10:03 AM  62. IN SITU CROSS-LINKABLE HYALURONAN FOR CARTILAGE REPAIR p. S40
  C. Aulin1, P. Hedenqvist2, M. Jensen-Waern3, J. Hilborn4, T. Engstrand5; 
1Karolinska Inst., Stockholm, SWEDEN, 2Swedish Univ. of agricultural Sci.s, Uppsala, SWEDEN, 
3Swedish Univ. of agricultural Sci.s, Uppsala, SWEDEN, 4Uppsala Univ., Uppsala, SWEDEN, 
5Karolinska Univ. Hosp., Stockholm, SWEDEN.
10:03 AM – 10:15 AM  63. THE CHONDROPROTECTIVE EFFECT OF FGF9 IN AN EXPERIMENT MODEL OF OSTEOARTHRITIS p. S40
  S. X. Wang1, A. M. Bendele2, E. M. Moore3; 
1Synarc, Newark, CA, 2Bolder BioPATH, Boulder, CO, 3Omeros, Seattle, WA.
8:45 AM – 10:15 AM Concurrent Session 10
Room 112 Epigenetics
 Session Chairs:
 Antonio Gonzalez, MD, PhD
 Ingrid Meulenbelt, PhD
8:45 AM – 9:15 AM I - 15. Epigenetics: Marks for Future OA Research p. S5
	 David	Young,	PhD
9:15 AM – 9:27 AM   64. INCREASED METHYLATION STATUS OF SOX9 GENE PROMOTER IN HUMAN OSTEOARTHRITIC  p. S41 
CARTILAGE
  K. Kim, J. Lee, J. Lee, G-I. Im; 
Dongguk Univ. Ilsan Hosp., Goyang, KOREA, REPUBLIC OF.
9:27 AM – 9:39 AM   65. MICROARRAY STUDIES OF SYNOVIAL SPECIMEN OF EARLY HUMAN (CHECK) AND EXPERIMENTAL  p. S41 
OA IDENTIFY PATHWAYS AND PROCESSES ASSOCIATED WITH CARTILAGE DAMAGE
  A. B. Blom1, P. L. van Lent1, M. van den Bosch1, H. Cats2, P. M. van der Kraan1, W. B. van den Berg1; 
1Radboud Univ. Med. Ctr. Nijmegen, Nijmegen, NETHERLANDS, 2Sint Maartenskliniek, Nijmegen, 
NETHERLANDS.
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9:39 AM – 9:51 AM  66. IDENTIFICATION AND CHARACTERISATION OF MICRORNAS INVOLVED IN CHONDROCYTE  p. S42 
DIFFERENTIATION AND OSTEOARTHRITIS
  T. E. Swingler1, N. Crowe1, K. Sorefan1, L. Le1, G. Wheeler1, V. Carmont1, H. R. Elliott2, M. J. Barter2, 
M. Abu-Elmagd1, S. T. Donell1, R. P. Boot-Handford3, M. K. Hajihosseini1, A. Münsterberg1, T. Dalmay1, 
D. A. Young2, I. M. Clark1; 
1Univ. of East Anglia, Norwich, UNITED KINGDOM, 2Univ. of Newcastle, Norwich, UNITED 
KINGDOM, 3Univ. of Manchester, Norwich, UNITED KINGDOM.
9:51 AM – 10:03 AM   67. THE ANALYSIS OF THE GENOME-WIDE DNA METHYLATION PROFILE OF HUMAN ARTICULAR  p. S42 
CHONDROCYTES REVEALS DIFFERENT FORMS OF OA.
  J. Fernández-Tajes1, M. Fernández-Moreno1, M. Tamayo-Novás2, A. Mosquera-Rey2, N. Oreiro-Villar1, 
C. Fernández-López1, J. L. Fernández-García2, I. Rego-Pérez1, F. J. Blanco1; 
1INIBIC-CHUAC. Rheumatology Div.. Genomic Group., A Coruña, SPAIN, 2INIBIC-CHUAC. 
Genetic Dept.., A Coruña, SPAIN.
10:03 AM – 10:15 AM  68. COMPARISON OF OSTEOARTHRITIS AND NORMAL HIP CARTILAGE TRANSCRIPTOMES USING  p. S43 
RNA-SEQ REVEALS NEW CANDIDATE GENE TARGETS AND ASSOCIATED PATHWAYS
  Y. Xu, M. J. Barter, D. C. Swan, K. S. Rankin, A. D. Rowan, M. Santibanez-Koref, J. Loughlin, 
D. A. Young;  
Newcastle Univ., Newcastle upon Tyne, UNITED KINGDOM.
10:15 AM – 10:45 AM BREAK 
10:45AM – 12:15PM Debate: Is OA a Mechanical Disease or an 




10:45 AM – 11:15 AM Mechanical Disease 
		 David	Felson,	MD,	MPH
11:15 AM – 11:45 AM I - 16. Inflammatory Disease 
		 Francis	Berenbaum,	MD,	PhD
11:45 AM – 12:15 PM Discussion
12:30 PM – 2:00 PM I - 17. Challenges in Studying Risk Factors for OA Progression – A Workshop for Young Investigators p. S5
Room 131 + 132  Yuqing	Zhang,	DSc
2:00 PM – 3:30 PM Concurrent Session 11
Room 111 Chondrocyte Physiology 
 Session Chairs:
 Martin Lotz, MD
 Frédéric Mallein-Gerin, PhD
2:00 PM – 2:30 PM  I - 18. What Makes Chondrocytes Special? p. S5
	 Timothy	Hardingham,	BSc,	PhD,	DSc
2:30 PM – 2:42 PM  69. SUBSTANTIAL ALTERATION OF POST-TRANSCRIPTIONAL GENE CONTROL IN CHONDROCYTES FROM  p. S43 
OSTEOARTHRITIC JOINTS
  S. R. Tew, B. McDermott, O. Vasieva, P. D. Clegg; 
Univ. of Liverpool, Liverpool, UNITED KINGDOM.
2:42 PM – 2:54 PM  70. INHIBITION OF WNT/B-CATENIN PATHWAY BY SCLEROSTIN PROMOTES CARTILAGE MAINTENANCE p. S43
  W. Bouaziz, T. Funk-Brentano, H. Lin, E. Hay, M. Cohen-Solal; 
INSERM606, Paris, FRANCE.
2:54 PM – 3:06 PM 71. ROLE OF STROMAL CELL-DERIVED FACTOR-1 ALPHA ON ENDOCHONDRAL OSSIFICATION p. S44
  G. Kim1,2, S. Han1,2, Y. Jung2, S. Usmani3,4, V. Ulici3,4, F. Beier3,4; 
1Daegu fatima Hosp., Daegu, KOREA, REPUBLIC OF, 2Lab. for arthritis and bone biology, Fatima 
research Inst., Daegu, KOREA, REPUBLIC OF, 3Dept. of Physiology and Pharmacology, Univ. of 
Western Ontario, London, ON, CANADA, 4CIHR Group in Skeletal Dev. and Remodeling, London, 
ON, CANADA.
3:06 PM – 3:18 PM  72. NG2/CSPG4 REGULATES AGGRECANASE AND MMP EXPRESSION IN HUMAN CHONDROCYTES p. S44
  N. S. Jamil, A. Azfer, H. E. Sarah, D. M. Salter; 
Univ. of Edinburgh, Edinburgh, UNITED KINGDOM.
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3:18 PM – 3:30 PM   73. ACTIVATION OF AMP-ACTIVATED PROTEIN KINASE (AMPK) INHIBITS CHONDROCYTE CATABOLIC  p. S45 
RESPONSE TO PRO-INFLAMMATORY CYTOKINES AND UP-REGULATES ANTI-OXIDANT GENES VIA  
PPAR COACTIVATOR 1 (PGC-1) AND FORKHEAD BOX O FACTOR 3 (FOXO3A)
  X. Zhao1, R. Terkeltaub1, M. Lotz2, R. Liu-Bryan1; 
1VAMC, UCSD, San Diego, CA, 2The Scripps Res. Inst., La Jolla, CA.
2:00 PM – 3:30 PM Concurrent Session 12 
Room 112 New Genomic Technologies for the Study of OA   
 Session Chairs:
 John Loughlin, PhD 
 Rik Lories, MD, PhD
2:00 PM – 2:30 PM I - 19. New Genomic Technologies for the Study of OA p. S6 
		 Ingrid	Meulenbelt,	PhD
2:30 PM – 2:42 PM  74. TOWARDS GENE-BASED ANALYSIS OF GENOME-WIDE ASSOCIATION OSTEOARTHRITIS DATA p. S45
  A. Gonzalez1, C. Rodriguez-Fontenla1, M. Calaza1, E. Evangelou2, J. J. Gomez-Reino1, Translation 
Research in Europe Applied Technologies for Osteoarthritis (TreatOA);  
1Hosp. Clinico Univ.rio de Santiago, Santiago de Compostela, SPAIN, 2Univ. of Ioannina Sch. of Med., 
Ioannina, GREECE.
2:42 PM – 2:54 PM   75. THE OSTEOARTHRITIS SUSCEPTIBILITY GENE GDF5 IS UNDER EPIGENETIC REGULATION BY DNA  p. S45 
METHYLATION - THE MOLECULAR INTERPLAY BETWEEN GENETICS AND EPIGENETICS IN DISEASE RISK
  L. N. Reynard, C. M. Syddall, J. Loughlin; 
Newcastle Univ., Newcastle upon Tyne, UNITED KINGDOM.
2:54 PM – 3:06 PM   76. ALLELIC EXPRESSION ANALYSIS IN PATIENT TISSUES OF THE OSTEOARTHRITIS AND OF THE  p. S46 
LUMBAR DISC HERNIATION SUSCEPTIBILITY LOCI THAT MAP TO COL11A1
  A. W. Dodd, E. V. Raine, L. N. Reynard, J. Loughlin; 
Newcastle Univ., Newcastle upon Tyne, UNITED KINGDOM.
3:06 PM – 3:18 PM   77. A GENETIC ANALYSIS OF OSTEOARTHRITIS OF THE KNEE IN NORTH AMERICAN CAUCASIANS:  p. S46 
RESULTS FROM THE OSTEOARTHRITIS INITIATIVE AND JOHNSTON COUNTY OSTEOARTHRITIS PROJECT
  L. M. Yerges-Armstrong1, C. Lu1, M. C. Hochberg1, B. Mitchell1, J. M. Jordan2, J. B. Renner2, 
T. McSherry3, D. M. Taverna3, D. Duggan3, W. J. Mysiw4, R. Jackson4; 
1Univ. of Maryland, Baltimore, MD, 2Univ. of North Carolina, Chapel Hill, NC, 3TGen, Pheonix, AZ, 
4The Ohio State Univ., Columbus, OH.
3:18 PM – 3:30 PM   78. THE IDENTIFICATION OF TRANS-ACTING FACTORS THAT DIFFERENTIALLY REGULATE THE  p. S46 
EXPRESSION OF GDF5 VIA THE OSTEOARTHRITIS ASSOCIATED SNP RS143383
  C. M. Syddall, L. N. Reynard, D. A. Young, J. Loughlin; 
Newcastle Univ., Newcastle upon Tyne, UNITED KINGDOM.
3:30 PM – 5:00 PM Poster Session 2: Presenters in Attendance 
Exhibit Hall
 Even Posters 3:30PM – 4:15 PM
 Odd Posters 4:15 PM – 5:00 PM
5:00 PM – 6:06 PM Plenary Session 4 
Room 111 + 112 Pain Sensitivity in OA
 Session Chairs: 
 Anne-Marie Malfait, MD, PhD
 Thomas Schnitzer, MD, PhD
5:00 PM – 5:30 PM   I - 20. Clinical Pain Severity and Experimental Pain Sensitivity in OA  p. S6 
Yvonne	Lee,	MD
5:30 PM – 5:42 PM  79. BRAIN FUNCTIONAL PROPERTIES PREDICT PLACEBO ANALGESIA IN KNEE OSTEOARTHRITIS p. S47
  A. Mansour, M. Baliki, T. J. Schnitzer, A. V. Apkarian; 
Northwestern Univ., Chicago, IL.
5:42 PM – 5:54 PM  80. PAIN PERCEPTION IN HAND OSTEOARTHRITIS: RELATION BETWEEN CLINICAL NODES,  p. S47 
RADIOLOGICAL SEVERITY, PAIN THRESHOLD AND BRAIN PAIN PROCESSING
  N. Sofat, J. Wajed, C. Smee, M. Hermansson, F. Howe, T. R. Barrick; 
St George’s, Univ. of London, London, UNITED KINGDOM.
5:54 PM – 6:06 PM   81. RACIAL DIFFERENCES IN PAIN REPORTING IN SUBJECTS WITH OR AT RISK FOR SYMPTOMATIC  p. S47 
RADIOGRAPHIC KNEE OSTEOARTHRITIS: DATA FROM THE OSTEOARTHRITIS INITIATIVE
  P. Luneburg, L. Yerges-Armstrong, B. Mitchell, M. C. Hochberg; 
Univ. of Maryland, Baltimore, MD.
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7:00 PM – 10:00 PM CONGRESS DINNER
 National Art Museum of Catalonia (MNAC) 
 **Ticketed Event.
Sunday, April 29, 2012
7:30 AM – 8:30 AM Breakfast Workshop E – 
 I- 21. New Guidelines on Publishing Animal Studies p. S6
Room 131 + 132 Christopher Little, PhD 
 **Ticketed Workshop.
7:30 AM – 8:30 AM  Breakfast Workshop F – 
 I - 22. State of Art in Managing Hand OA p. S6
Room 133 + 134	 Leonardo	Punzi,	MD,	PhD
  **Ticketed Workshop.
8:45 AM – 10:15 AM Concurrent Session 13
Room 111 Injury and OA  
  Session Chairs: 
Victor Goldberg, MD 
Steven R. Goldring, MD
8:45 AM – 9:15 AM I - 23. Pathophysiology of Post-Traumatic OA  p. S7 
 Steven R. Goldring, MD
9:15 AM – 9:27 AM   82. P-188, ANTI-TNF- AND OP-1: A NOVEL TRIAD IN THE PREVENTION OF POST-TRAUMATIC  p. S48
OSTEOARTHRITIS
  R. Olewinski, A. Hakimiyan, L. Rappoport, C. Pacione, M. Wimmer, S. Chubinskaya; 
Rush Univ. Med. Ctr., Chicago, IL.
9:27 AM – 9:39 AM   83. INTRA-ARTICULAR BLOOD COAGULATION AGGRAVATES JOINT DAMAGE AFTER A BLEED IN  p. S49 
A CANINE IN VIVO MODEL
  M. E. van Meegeren, G. Roosendaal, A. D. Barten-van Rijbroek, S. C. Mastbergen, F. P. Lafeber; 
Univ. Med. Ctr. Utrecht, Utrecht, NETHERLANDS.
9:39 AM – 9:51 AM   84. DEPLETION OF PERLECAN DOMAIN I HEPARAN SULFATE REGULATES FIBROBLAST GROWTH  p. S49 
FACTOR ACTIVITY IN CARTILAGE AND PROTECTS AGAINST CARTILAGE LOSS AND OSTEOPHYTE  
DEVELOPMENT IN POST-TRAUMATIC OSTEOARTHRITIS
  C. C. Shu, C. B. Little, J. Melrose; 
Kolling Inst. of Med. Res., Sydney, AUSTRALIA.
9:51 AM – 10:03 AM  85. TRANSCRIPTIONAL REGULATION DURING THE DEVELOPMENT OF SURGICALLY-INDUCED OA IN MICE p. S50
  R. F. Loeser, Jr.1, A. L. Olex2, M. McNulty3, C. S. Carlson3, M. Callahan1, C. Ferguson1, J. S. Fetrow2; 
1Wake Forest Sch. of Med., Winston Salem, NC, 2Wake Forest Univ., Winston Salem, NC, 3Univ. of 
Minnesota, St. Paul, MN.
10:03 AM – 10:15 AM  86. PRECLINICAL INVESTIGATION OF THE DEVELOPMENT OF OSTEOARTHRITIS-LIKE DEGENERATION  p. S50 
IN A RAT TRAUMA MODEL USING MICRO-COMPUTED TOMOGRAPHY
  T. H. Steiner1, R. J. Choo1, A. Quintin2, M. Wilke2, D. Nesic2, M. Zulliger3, R. Müller1, K. S. Stok1; 
1ETH Zurich, Zurich, SWITZERLAND, 2Univ. of Bern, Bern, SWITZERLAND, 3SCANCO Med. AG, 
Brüttisellen, SWITZERLAND.
8:45 AM – 10:15 AM Concurrent Session 14
Room 112 Regenerative Medicine and OA 
  Session Chairs: 
Angel Raya, MD, PhD
8:45 AM – 9:15 AM  I - 24. Regenerative Medicine Approaches for the Treatment and  p. S7
 Prevention of Osteoarthritis 
		 Cosimo	De	Bari,	MD,	PhD
9:15 AM – 9:27 AM   87. COMPARATIVE PROTEOMIC ANALYSIS OF BONE MARROW MESENCHYMAL STEM CELLS FROM  p. S51 
OA AND HEALTHY PATIENTS UNDERGOING CHONDROGENIC DIFFERENTIATION
  B. Rocha, J. Mateos, V. Calamia, C. Ruiz-Romero, F. J. Blanco; 
Osteoarticular and Aging Res. Lab., Proteomics Unit-Associated Node to ProteoRed-ISCIII,  
INIBIC-CHUAC, A Coruña, SPAIN.
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9:27 AM – 9:39 AM   88. LONG-TERM DETECTION OF HUMAN ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS  p. S51 
AFTER INTRA- ARTICULAR INJECTION
  K. Toupet, Jr.1, M. Maumus, Jr.1, J-A. Peyrafitte2, P. Bourin, Sr.2, C. Jorgensen, Sr.1, D. Noel, Sr.1; 
1Inserm U844, Montpellier, FRANCE, 2EFS-PM, Toulouse, FRANCE.
9:39 AM – 9:51 AM  89. INHIBITORY EFFECT OF MIR-29A ON THE CHONDROGENIC DIFFERENTIATION OF MESENCHYMAL  p. S52 
STEM CELLS
  D. Guérit, Jr., D. Philipot, Jr., J-M. Brondello, Sr., P. Chuchana, Sr., C. Jorgensen, Sr., D. Noël, Sr.; 
Inserm U844, Montpellier, FRANCE.
9:51 AM – 10:03 AM   90. MIGRATION POTENTIAL OF MESENCHYMAL STEM CELLS DERIVED FROM OSTEOARTHRITIC  p. S52 
PATIENTS AND THEIR SUITABILITY FOR IN SITU TISSUE REPAIR
  T. Dehne, K. Gulich, T. Häupl, M. Sittinger, J. Ringe; 
Charite - Univ.etsmedizin Berlin, Berlin, GERMANY.
10:03 AM – 10:15 AM  91. AN IN VIVO TRACKING SYSTEM TO INVESTIGATE THE MIGRATION OF BONE MARROW STEM  p. S52 
CELLS IN AN OSTEOCHONDRAL DEFECT MODEL
  J. Lee1, B-S. Kim2, H. Lee3, G-I. Im1; 
1Dongguk Univ. Ilsan Hosp., Goyang, KOREA, REPUBLIC OF, 2Seoul Natl. Univ., Seoul, KOREA, REPUBLIC OF, 
3KAIST, Daejeon, KOREA, REPUBLIC OF.
10:15 AM – 10:45 AM BREAK
10:45 AM – 12:15 PM Plenary Session 5 – Year in Review
Room 111 + 112
  Session Chairs: 
Francisco	Blanco,	MD,	PhD	
Francois	Rannou,	MD,	PhD
 I - 25. Clinical  p. S8
		 Marc	Hochberg,	MD,	MPH
 I - 26. Rehabilitation and Outcomes  p. S8
	 Ewa	Roos,	PT,	PhD
  I - 27. Biology p. S8
	 Peter	van	der	Kraan,	PhD
 Genetics and Genomics 
 Joyce van Meurs, PhD
 I - 28. Biomarkers  p. S8
	 Ali	Mobasheri,	BSc	ARCS,	MSc,	DPhil
 I - 29. Imaging  p. S9
	 Frank	Roemer,	MD
